1.Dose escalation of lobaplatin combined with ifxed docetaxel in second-line chemotherapy with solid tumors
Yuee LIU ; Xiaocang REN ; Xueji CHEN ; Yan MA ; Jing LI ; Yu PENG ; Zhijun GUO ; Bin CAO ; Qiang LIN
China Oncology 2015;(3):211-216
Background and purpose: Malignant tumors often relapsed or metastasized after first-line chemotherapy and needed second-line or above treatment. We conducted this study to deifne the maximum-tolerated dose (MTD) of lobaplatin with ifxed docetaxel for Chinese patients in previously treated solid tumors. Methods:Escalating doses of lobaplatin with fixed docetaxel were administered in a modified Fibonacci sequence. The initial doses were lobapla-tin 30 mg/m2 and docetaxel 60 mg/m2, respectively. Escalating doses was 5 mg/m2. The regimen was repeated every 21 days. If no dose-limiting toxicity (DLT) was observed, the next dose level was applied. The procedures were repeated until DLT appeared. The MTD was declared to be one dose level below the level at which DLT appeared. Results:Seventeen patients received fifty-eight cycles chemotherapy at lobaplatin of levelⅠ(30mg/m2), levelⅡ(35 mg/m2)and levelⅢ(40 mg/m2). Cases of complete response (CR), partial response (PR), stable disease (SD) and progression disease (PD) for the whole group were 0, 1, 10 and 3, respectively. Response rate (RR, CR+PR) and disease control rate (DCR, CR+PR+SD) were 7.1%(1/14) and 78.6%(11/14), respectively. The most common toxicity was leukopenia. Three DLTs occurred in 3 patients in the whole group, including 2 DLTs in dose levelⅢ. We declared thus levelⅡwas MTD. Conclusion:MTD of lobaplatin in our re-search was 35 mg/m2 combined with fixed dose of docetaxel. This combination regimen was well tolerated.
2.Therapeutic review of 23 subependymal giant-cell astrocytoma
Lijiang HAN ; Jizong ZHAO ; Zhenyu MA ; Song LIN ; Yuanli ZHAO ; Ge YUAN ; Nan JI ; Yongji TIAN ; Tong REN ; Dong ZHANG ; Zhenrong SUN ; Xinru XIAO ; Kai TANG ; Mingxue PIAO ; Xueji LI ; Hai LIU ; Xun YE ; Xiaolin CHEN
Chinese Journal of Postgraduates of Medicine 2009;32(23):18-21
Objective To analyze and estimate, the treatment of patients with histologically confirmed subependymal giant-cell astroeytoma (SEGCA). Methods The data from 23 patients with SEG-CA who were diagnosed between February 1995 and February 2008 were retrospectively evaluated. Various combinations of surgery and radiotherapy had been used for treatment. Results Total resection was 16 cases, subtotal resection was 7 cases, radiotherapy was 17 cases. The average follow-up time was 53 months.One postoperative SEGCA recurrence. Epilepsy was totally disappeared in 17.6% (3/17), partly disappeared in 47.1%(8/17). All cases survived. Conclusions The key of treatment is total resection. The significance of radiotherapy is not sure. The overall prognosis of SEGCA is favorable.
3.Central neurocytoma: analysis of 71 cases
Lijiang HAN ; Jizong ZHAO ; Shuo WANG ; Ge YUAN ; Nan JI ; Yongji TIAN ; Tong REN ; Dong ZHANG ; Zhenrong SUN ; Xinru XIAO ; Kai TANG ; Mingxue PIAO ; Xueji LI ; Hai LIU ; Xun YE ; Xiaolin CHEN
Chinese Journal of Postgraduates of Medicine 2009;32(17):1-4
Objective To examine the diagnosis and outcomes in the treatment of the patients with histologically confirmed central neurocytoma (CNC). Methods The data from 71 patients with CNC who were diagnosed between March 2003 and December 2007 were retrospectively evaluated. Various combinations of surgery, and radiotherapy had been used for treatment. Results The average bulk of tumors was 40 cm3. The median follow-up was 22 months. The 22 months overall survival and local control rate was 95.8%(68/71) and 95.6%(65/68), respectively. Conclusions The overall prognosis is favorable although the follow-up is not very long. Surgery and postoperative radiotherapy can significantly improve local control.
4.Prevalence of hypertension and risk factors in Uygur population in Kashgar area of Xinjiang Uygur Autonomous Region
Zhoubin ZHANG ; Zhenxiang XUE ; Haiyan CHEN ; Tongmin WANG ; Yaohui LI ; Xianfeng CHAO ; Gang WANG ; Dongmei LUO ; Xueji WU ; Nurmamat NAZIBAM ; Ayxamgul BAWUDUN ; Elyas GULBAHAR· ; Ziyan ZHOU ; Baoshan SUN ; Yuzhong WANG ; Ming WANG
Chinese Journal of Epidemiology 2017;38(6):709-714
Objective To investigate the prevalence of hypertension and risk factors in Uygur adults in Kashgar of Xinjiang.Methods A total of 4 748 Uygur adults aged ≥ 18 years selected through cluster random sampling in Shufu county of Kashgar prefecture were surveyed by means of questionnaire survey,physical examination and laboratory test.The prevalence,awareness,treatment and control rate of hypertension of different groups were calculated and risk factors of hypertension was analyzed by using non-conditional logistic regression model.Results The overall prevalence of hypertension was 15.73% (age-adjusted prevalence was 13.75%).The prevalence rates of hypertension in men and women were 16.36% (age-adjusted prevalence was 12.96%),15.39% (age-adjusted prevalence was 14.34%),respectively.The rates of awareness,treatment and control of hypertension were 59.57%,52.74%,21.29%,respectively.The prevalence of hypertension increased with age.Compared with age group 18-34 years,the age groups 55-64,≥65 years had higher risk of hypertension and the OR values were 10.53,20.96 for men and 16.27,33.20 for women.The overweight (OR=1.47 for men,OR =1.82 for women,P<0.05) and obesity (OR =1.88 for men,OR=2.66 for women,P<0.05) also increased the risk of hypertension.The groups with family history of hypertension (OR=3.85 for men,OR=2.34 for women,P<0.05) also had higher risk of hypertension.Hypertriglyceridemia was positively correlated with the prevalence of hypertension in men (OR=1.62,95%CI:1.09-2.41).Conclusions The prevalence of hypertension in Uygur adults in Kashgar area of Xinjiang was at relatively low level.The related risk factors were age,overweight,obesity,family history and hypertriglyceridemia in men and the risk factors were similar in women except hypertriglyceridemia.